Large-scale testing (Phase 3)Study completedNCT01282268
What this trial is testing
Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Who this might be right for
Fragile X Syndrome
Seaside Therapeutics, Inc. 125